Amarin Corp Plc (AMRN)

[Birdbrain Ideas]

You raise a great point about the bad blood between Amarin's lawyers and officials and those working for generic companies. But I think the change in lawyers and owners, particularly with the retirement of Kennedy and JT, gives Amarin a fresh chance to change its dialogue with the generics, whether the Supreme Court takes up the case or not.

It does seem exceedingly penny wise and pound foolish for generics to be so nasty in their dealings with Amarin. Going to the New York attorney general's office and a federal agency and trying to get them to go after Amarin for allegedly cornering the market was pathetic. And, presumably after investigators concluded there was no case there, to sue Amarin with the claims seemed desperate.

And all of this to fight for between 10 percent and 40 percent of a small pie? It would seem smarter for generics to strike a deal that would let them enter the market in the summer of 2028 with access to the full label. Amarin, if it was feeling generous, could even help teach them how to develop their product so it doesn't stink when people take it. In return, Amarin would get a few years to properly promote Vascepa so that generics could then have decades of selling a product that would have two to three times the sales it otherwise might have. But of course a settlement is off the table unless the Supreme Court surprises us and takes up the case.